SpectraScience Optical Biopsy
This article was originally published in The Gray Sheet
Executive Summary
Modular PMA is filed with FDA for detection of colorectal cancer. Intended to expedite the standard PMA review process, the modular process "should enable us to achieve our goal of obtaining FDA clearance to market in the first quarter of 1999," SpectraScience says